Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Accounts Payables (2016 - 2024)

Historic Accounts Payables for Zepp Health (ZEPP) over the last 9 years, with Q4 2024 value amounting to $51.1 million.

  • Zepp Health's Accounts Payables rose 3892.04% to $51.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $51.1 million, marking a year-over-year increase of 3892.04%. This contributed to the annual value of $51.1 million for FY2024, which is 3698.71% up from last year.
  • Zepp Health's Accounts Payables amounted to $51.1 million in Q4 2024, which was up 3892.04% from $36.8 million recorded in Q4 2023.
  • Zepp Health's Accounts Payables' 5-year high stood at $294.4 million during Q4 2020, with a 5-year trough of $36.8 million in Q4 2023.
  • Moreover, its 5-year median value for Accounts Payables was $64.2 million (2022), whereas its average is $130.5 million.
  • In the last 5 years, Zepp Health's Accounts Payables crashed by 6884.2% in 2022 and then surged by 3892.04% in 2024.
  • Zepp Health's Accounts Payables (Quarter) stood at $294.4 million in 2020, then crashed by 30.02% to $206.0 million in 2021, then plummeted by 68.84% to $64.2 million in 2022, then plummeted by 42.73% to $36.8 million in 2023, then skyrocketed by 38.92% to $51.1 million in 2024.
  • Its Accounts Payables stands at $51.1 million for Q4 2024, versus $36.8 million for Q4 2023 and $64.2 million for Q4 2022.